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ABSTRACT
Background: The SYNTAX score was developed as an an-
giographic tool to grade the complexity of coronary artery 
disease in patients with three-vessel and/or left main disease. 
The role of this score in predicting clinical outcomes after 
percutaneous coronary intervention (PCI) in non-selected 
patients treated in the daily clinical practice of a referral 
centre was evaluated. Methods: Analysis of patients under-
going PCI from March to September of 2009, and at the 
12-month follow-up. Patients were divided into tertiles ac-
cording to the SYNTAX score. The primary endpoint included 
major adverse cardiac events (MACE) – death, non-fatal acute 
myocardial infarction, and target-vessel revascularisation. The 
ability of the SYNTAX score to predict MACE was assessed 
by the receiver operator characteristic (ROC) curve. Results: 
Two hundred and thirty-four patients with a mean SYNTAX 
score of 11.6  ±  6.2 points were included. Tertile I had a 
SYNTAX score ≤  9 (average 5.9); tertile II, >  9 and ≤  13 
(average 10.8); and tertile III, >  13 (average 18.3). During 
the clinical follow-up of 7.2 ± 4.9 months, the incidence of 
MACE was greater in tertile III than in tertiles I and II (2.5% 
vs. 6.4% vs. 14.1%; P  =  0.0075). The ROC curve showed 
an area under the curve of 0.667 (P  =  0.012), indicating a 
moderate ability to anticipate the occurrence of MACE in 
this population. Conclusions: The SYNTAX score proved to 
be useful in predicting the occurrence of MACE after PCI in 
patients treated in clinical practice.
DESCRIPTORS: Coronary artery disease. Angioplasty. Stents. 
Drug-eluting stents. Prognosis.
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RESUMO
Impacto da Utilização do Acesso Radial na  
Ocorrência de Sangramento Grave entre Idosos 
Submetidos a Intervenção Coronária Percutânea
Introdução: O escore SYNTAX foi desenvolvido como ferra-
menta para graduar a complexidade angiográfica da doença 
arterial coronária em pacientes com acometimento de três vasos 
e/ou com lesão de tronco. Avaliamos seu papel em predizer 
desfechos clínicos após intervenção coronária percutânea (ICP) 
em pacientes não-selecionados, tratados na prática diária de 
um hospital de referência. Métodos: Análise de pacientes 
submetidos a ICP entre março e setembro de 2009 e acom-
panhados por até 12 meses. Os pacientes foram divididos em 
tercis de acordo com o escore SYNTAX. O desfecho primário 
foi composto de eventos cardíacos adversos maiores (ECAM) – 
óbito, infarto agudo do miocárdio não-fatal e revascularização 
do vaso-alvo. O desempenho do escore SYNTAX em predizer 
ECAM foi avaliado pela curva ROC (Receiver Operator Cha ­
racteristic). Resultados: Foram incluídos 234 pacientes com 
escore SYNTAX médio de 11,6 ± 6,2 pontos. O tercil I apre-
sentou escore SYNTAX ≤ 9 (média de 5,9); o tercil II, > 9 e 
≤ 13 (média de 10,8); e o tercil III, > 13 (média de 18,3). 
No seguimento clínico de 7,2 ± 4,9 meses, a incidência de 
ECAM foi maior no tercil III em comparação com os tercis 
I e II (2,5% vs. 6,4% vs. 14,1%; P = 0,0075). A curva ROC 
mostrou área sob a curva de 0,667 (P = 0,012), indicando 
moderada capacidade de prever a ocorrência de ECAM nessa 
população. Conclusões: O escore SYNTAX mostrou ser útil em 
prever a ocorrência de ECAM em pacientes pós-ICP tratados 
na prática clínica diária.
DESCRITORES: Doença das coronárias. Angioplastia. Stents. 
Stents farmacológicos. Prognóstico.
© 2012 Elsevier Editora Ltda. and Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. All rights reserved.
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T he SYNTAX score was developed as an angiographic tool to grade the complexity of coronary artery disease (CAD), and it has been used to determine 
the prognosis of patients with triarterial CAD and/or 
those with lesions in the left main coronary artery; this 
score aids decision-making regarding the best revascu-
larisation strategy, whether percutaneous or surgical.1–4 
Recent data also indicate the usefulness of the SYNTAX 
score to predict the development of periprocedural 
myocardial infarction in patients undergoing elective 
percutaneous coronary intervention (PCI).5
The SYNTAX study, which first described the score, 
compared late clinical outcomes in patients with mul-
tivessel disease treated with PCI and paclitaxel-eluting 
stents versus coronary artery bypass graft (CABG) 
surgery.2 The unfavourable PCI results in patients with 
higher anatomic complexity confirmed the limitation 
of interventionist techniques in such cases.
Even with advances in PCI techniques and the avail-
ability of new devices, such as second-generation of 
drug-eluting stents, currently, the percutaneous treatment 
of CAD remains limited to cases of low to moderate 
anatomic complexity. Presently, in Brazil, drug-eluting 
stents are not available in the public health system, 
and the public health system does not reimburse the 
institution when more than two stents are implanted 
in the same procedure.
In the present study, the SYNTAX score was applied 
to a non-selected patient population treated with PCI 
in a tertiary centre within the public health system in 
the state of São Paulo; its performance as a prognostic 
tool was evaluated immediately in-hospital and for 
medium-term evolution.
METHODS
This was a retrospective study performed in a single 
centre using a database with prospectively-collected 
data, which evaluated the SYNTAX angiographic score 
regarding in-hospital and medium-term clinical out-
comes of patients undergoing PCI attended to in daily 
clinical practice.
Patients treated with drug-eluting and bare-metal 
stents between March and September 2009, either 
electively or due to acute coronary syndrome, were 
included. All interventions were performed according 
to the indications established in the current guidelines6 
following standard techniques, and all patients signed 
an informed consent before the procedure.
Patients who had all arterial territories treated in a 
single procedure and those who underwent staged proce-
dures, provided they were performed within 30 days of the 
index procedure, were included. Patients who underwent 
previous PCI with stent implantation or CABG surgery 
were excluded. Patients who were not followed-up in 
the institution after PCI were also excluded.
Information on the clinical characteristics, proce-
dures and adverse events was obtained from records 
in the data bank and medical records.
Pre-procedure coronary angiographies of all patients 
included in this study were analysed, and the SYNTAX 
score was calculated by two interventional cardiologists 
using instructions and programs available at the official 
SYNTAX score website (www.syntaxscore.com). Patients 
were divided into tertiles according to the SYNTAX 
score and were evaluated regarding the development 
of in-hospital and late adverse events.
Major adverse cardiac events (MACE – outcomes 
such as cardiac death, non-fatal acute myocardial 
infarction, and new revascularisation of the target-
vessel by clinical indication) in late follow-up were 
considered the primary outcome. All deaths were 
considered to be from cardiac cause unless another 
cause had been established. Confirmation of acute 
myocardial infarction was achieved by evidence of 
elevated serum markers of myocardial necrosis (> three 
times the upper limit for creatine kinase-MB fraction) 
associated with symptoms or electrocardiographic 
evidence of myocardial ischemia. Q-wave infarctions 
were defined by new pathologic Q waves on elec-
trocardiogram (two or more contiguous derivations) 
or new left bundle branch block in addition to the 
biomarker changes. Revascularisation of the target-
vessel was defined as new revascularisation of the 
treated coronary artery. Chronic renal disease was 
defined as the presence of a creatinine clearance 
<  60  mL/min before the procedure.
Secondary outcomes included the success of the 
procedure, isolated death rates, non-fatal myocardial 
infarction, and revascularisation of the target-vessel, 
in addition to definitive or probable stent thrombosis 
(according to the definition of the Academic Research 
Consortium – ARC).7
Categorical variables were expressed as absolute 
frequencies and percentages, and continuous variables 
were expressed as the mean and standard deviation. 
Data were compared according to the tertiles of the 
SYNTAX score and by using the chi-squared test or 
Fisher’s exact test for categorical variables, or ANOVA for 
continuous variables. P-values < 0.05 were considered 
statistically significant. The capacity of the SYNTAX score 
to discriminate patients with MACE was evaluated by 
the receiver operating characteristic (ROC) curve. The 
SAS and XLSTAT 2011 statistical programs were used.
RESULTS
In the period evaluated, 234 patients undergoing 
PCI fulfilled inclusion criteria. The mean age of the 
population was 59.8  ±  9.7 years, and 71.4% of the 
patients were males. Two hundred ninety-seven vessels 
were treated with the implantation of 339 stents (mean 
of 1.44 ± 0.32 stents per patient and 1.14 ± 0.11 stents 
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per vessel). The mean follow-up time was 7.2  ±  4.9 
months.
The SYNTAX score ranged from 1 to 57.5 points, 
with a predominance of patients with low SYNTAX scores 
(0 to 22), according to the original classification (222 
patients or 94.8%), 11 (4.7%) patients had an intermediate 
SYNTAX score (23 to 32), and only one patient (0.4%) 
present an elevated SYNTAX score (≥ 33). Specifically in 
the latter case, it was decided to perform PCI due to the 
presence of severe comorbidities and an elevated surgical 
risk for CABG surgery.
The mean SYNTAX score in this population was 
11.6 ± 6.2 points. The median score in the population 
was 11 points. Patients were divided by tertiles, each 
with 78 patients. Patients in tertile I had a SYNTAX 
score ≤  9; in tertile II, patients had a SYNTAX score 
> 9 and ≤ 13; and in tertile III, patients had a SYNTAX 
score > 13. In the study population, the mean SYNTAX 
scores for tertiles I, II, and III were, respectively, 5.9, 
10.8, and 18.3.
The prevalence of risk factors for CAD was pro-
gressively greater with increased SYNTAX score, with a 
higher proportion of diabetic and dyslipidaemic patients 
in tertile III (Table 1).
Regarding the types of stents implanted, the majority 
of patients (81.6%) received bare-metal stents. There 
was no difference in the use of drug-eluting stents 
in tertiles I, II, or III (18.9%, 17.1%, and 21.9%; 
P = 0.57). The coronary territory most frequently 
treated was that of the left anterior descending artery, 
accounting for 38% of the procedures (113 interven-
tions). Procedural success was obtained in 98.7% of 
the cases in tertile I, in 96.2% of the cases in tertile 
II, and in 94.8% of the cases in tertile III (P = 0.17). 
Table 2 presents the angiographic characteristics and 
procedure data.
Differences among the tertiles for in-hospital MACE 
were not observed, but differences were observed in 
late MACE, with a higher number of combined events 
in tertile III compared with tertiles I and II (2.5% in 
tertile I, 6.4% in tertile II, and 14.1% in tertile III; 
P = 0.0075) (Table 3). Regarding secondary outcomes, 
the incidence of isolated adverse events was greater in 
the group with higher SYNTAX scores (tertile III), but this 
difference was not statistically significant. During the 
follow-up period, stroke was not diagnosed, and cases 
of definitive stent thrombosis were not documented. 
One of the two deaths observed in tertile III fulfilled 
the criteria for probable stent thrombosis (unexplained 
death within 30 days of the procedure). The other 
death was attributed to complications secondary to 
decompensated congestive heart failure.
The ROC curve, constructed to measure the perfor-
mance of the SYNTAX score, showed an area under the 
curve of 0.667 (P = 0.012), demonstrating a moderate 
capacity to predict the development of MACE in this 
population (Figure 1).
TABLE 1 
Baseline Clinical Characteristics
 
Variables
Tertile I
(n = 78)
Tertile II 
(n = 78)
Tertile III  
(n = 78) P
Mean age, years 58.6 ± 8.9 60.2 ± 9.9 61.4 ± 9.6 0.71
Male gender, n (%) 57 (73.1) 48 (61.5) 62 (79.5) 0.34
Hypertension, n (%) 65 (83.3) 70 (89.7) 71 (91) 0.15
Diabetes mellitus, n (%) 18 (23.1) 28 (35.9) 36 (46.1) 0.002
Dyslipidaemia, n (%) 47 (60.2) 56 (71.8) 62 (79.5) 0.008
Smoking, n (%) 16 (20.5) 11 (14.1) 17 (21.8) 0.21
Chronic kidney disease, n (%) 4 (5.1) 7 (8.9) 8 (10.2) 0.22
Clinical presentation, n (%) 0.19
Asymptomatic 17 (21.8) 12 (15.4) 11 (14.1)
Stable angina 45 (57.7) 45 (57.7) 48 (61.5)
ACS without ST-segment elevation 10 (12.8) 12 (15.4) 13 (16.6)
AMI with ST-segment elevation 6 (7.7) 9 (11.5) 6 (7.7)
n = number of patients; ACS = acute coronary syndrome; AMI = acute myocardial infarction.
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DISCUSSION
In this analysis, the SYNTAX score appeared to 
be capable of predicting MACE after PCI in a general 
population in which most patients treated had low 
angiographic complexity according to the original clas-
sification of the SYNTAX study.
The SYNTAX score is based on adding the complex-
ity points of each lesion >  50% of the cross-sectional 
area of the vessel, which are proportional to the lesion 
complexity as identified on coronariography.3 Even though 
its importance in selecting the appropriate myocardial 
revascularisation technique for different presentations 
of multiarterial CAD cannot be disputed, the SYNTAX 
score’s usefulness remains uncertain for patients with 
one- or two-vessel disease.
In the SYNTAX trial, the high score group (≥  33) 
undergoing PCI showed higher MACE and adverse cardiac 
TABLE 2 
Angiographic and Procedure Characteristics
 
Variables
Tertile I 
(n = 78)
Tertile II 
(n = 78)
Tertile III 
(n = 78)
 
P
Number of coronary arteries treated 86 96 115 0.32
Number of stents implanted 95 111 132 0.13
Coronary arteries with ≥ 70% lesion, n (%)
Uniarterial
Biarterial
Triarterial
64 (82.1)
12 (15.4)
2 (2.5)
47 (60.2)
20 (25.6)
11 (14.1)
14 (17.9)
32 (41.1)
32 (41.1)
< 0.001
Number of coronary arteries treated according  
to the anatomy (%)
LMCA
LAD
LCx
RCA
 
0
32 (37.2)
26 (30.2)
28 (32.5)
 
0
36 (37.5)
23 (23.9)
37 (38.5)
 
4 (3.5)
45 (39.1)
26 (22.6)
40 (34.7)
 
0.07
0.78
0.22
0.82
Number of stents used according to type (%)
Drug-eluting
Bare-metal
18 (18.9)
77 (81.1)
19 (17.1)
92 (82.9)
29 (21.9)
103 (78.1)
0.57
0.34
Number of lesions according to anatomic  
complexity (%)
Chronic total occlusion
Bifurcation
Moderate/severe calcification
Severe tortuosity
B2/C type lesions
 
0
9 (10.4)
0
5 (5.8)
16 (18.6)
 
4 (4.1)
22 (22.9)
11 (11.5)
12 (12.5)
43 (44.8)
 
13 (11.3)
37 (32.2)
26 (22.6)
14 (12.2)
81 (70.4)
 
< 0.001
< 0.001
< 0.001
0.12
< 0.001
LAD = left anterior descending artery; LCx = left circumflex artery; LMCA = left main coronary artery; RCA = right coronary artery;  
n = number of patients.
and cerebrovascular event rates (MACCE) compared with 
the group undergoing CABG surgery (23.4% vs. 10.9%; 
P = 0.001). Additionally, the rate of combined outcomes 
of death, acute myocardial infarction, and stroke showed 
a tendency to be more elevated in the group treated 
percutaneously (11.9% vs. 7.6%; P = 0.08).1 Previously, 
similar results had been reported in the three years of 
evolution of patients in the Arterial Revascularisation 
Therapies Study Part II – Sirolimus-eluting stents for the 
treatment of patients with multivessel de novo coronary 
artery lesions (ARTS II). In that study, multivariate analysis 
was performed to determine the independent predictors 
of MACE. It was demonstrated that the SYNTAX score 
was one of the strongest predictors of MACE (odds 
ratio [OR] 1.43, 95% confidence interval [95% CI] 
1.08–1.90; P = 0.014), as was diabetes mellitus (OR 
1.76, 95% CI 1.13–2.74; P = 0.012).8 This evidence was 
used to determine which patients would be ineligible 
for percutaneous revascularisation techniques, based 
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on higher anatomic complexity.
Other studies also analysed the SYNTAX score in 
different populations. A subanalysis of the Limus Eluted 
from a Durable versus Erodable Stent Coating (LEADERS)9 
study found a mean SYNTAX score of 13.3 (± 8.7) in 
a sample of 1,397 patients undergoing PCI. A lower 
MACE-free survival rate was observed in the tertile with 
higher SYNTAX scores (low = 92.2%; intermediate = 
TABLE 3 
Incidence of Major Adverse Cardiac Events
 
Event
Tertile I 
(n = 78)
Tertile II  
(n = 78)
Tertile III  
(n = 78)
 
P
In-hospital, n (%)
Death
Myocardial infarction
Target-vessel revascularisation
MACE
0
1 (1.3)
0
1 (1.3)
0
3 (3.8)
0
3 (3.8)
0
4 (5.1)
0
4 (5.1)
NA
0.17
NA
0.17
Late phase, n (%)
Death
Myocardial infarction
Target-vessel revascularisation
MACE
0
0
1 (1.3)
1 (1.3)
0
0
2 (2.5)
2 (2.5)
2 (2.5)
2 (2.5)
3 (3.8)
7 (8.9)
0.24
0.24
0.31
0.02
Cumulative MACE, n (%) 2 (2.5) 5 (6.4) 11 (14.1) 0.0075
MACE = major adverse cardiac events; n = number of patients; NA = not applicable.
91.1%; and high = 84.6%; P = 0.001). Higher mortal-
ity rates (low = 1.5%; intermediate = 2.1%; and high 
= 5.6%; P  =  0.002) and higher rates of target-vessel 
revascularisation were also observed (low = 6.3%; in-
termediate = 7.8%; and high = 11.3%; P  =  0.001).10 
The similarity of the mid-range SYNTAX score of that 
study with the present analysis is emphasised.
The Comparison of Zotarolimus-Eluting and 
Everolimus-Eluting Coronary Stents study, which 
analysed 2,292 patients, found a mean SYNTAX 
score of 14.7 points with a 12-month incidence of 
MACE of approximately 8.2% in the group of pa-
tients who received zotarolimus-eluting stents and 
of approximately 8.3% in the group who received 
everolimus-eluting stents (P = 0.42). Additionally, the 
global rate of combined outcomes, which included 
all cardiovascular events, was 14.6%.11 These rates 
are smaller than the event rate of 18.3% reported by 
the angiographic group in the Fractional Flow Reserve 
Versus Angiography for Multivessel Evaluation (FAME) 
study, which had a similar SYNTAX score distribution. 
In this last study, 1,005 patients with multivessel CAD 
were randomised for angiography or fractional flow 
reserve-guided PCI, and the SYNTAX score of both 
groups was 14.5 points.12
The authors believe that each institution should 
know the angiographic profile of the patients it treats 
and determine the clinical outcomes profile in that 
population. In addition to representing good medi-
cal practice, this model can be used for institutional 
quality control.
Figure 1 – SYNTAX score ROC curve used to predict major cardiac 
adverse events. AUC = area under the curve; ROC = receiver opera-
ting characteristic.
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Limitations of the study
Although this study provides important informa-
tion on the use of the SYNTAX score in daily PCI 
practice, it has some limitations. The first and main 
limitation is the small study population size. Addition-
ally, the mean clinical follow-up time of these patients 
(<  12 months) was not long enough to characterise 
post-PCI adverse cardiac events, and the diversity of 
stent types used may have confounded the interpreta-
tion of the results.
CONCLUSIONS
The SYNTAX score, when applied to a population 
of patients with low/moderate anatomic complexity 
treated with PCI in daily clinical practice, allows for 
risk stratification of medium-term MACE outcomes.
CONFLICTS OF INTEREST
The authors declare no conflicts of interest.
REFERENCES
1. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, 
Mack MJ, et al. Percutaneous coronary intervention versus 
coronary-artery bypass grafting for severe coronary artery 
disease. N Engl J Med. 2009;360(10):961-72.
2. Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, 
Kappetein AP, et al. Assessment of the SYNTAX score in the 
Syntax study. EuroIntervention. 2009;5(1):50-6.
3. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, 
Dawkins K, et al. The SYNTAX score: an angiographic tool 
grading the complexity of coronary artery disease. EuroInter-
vention. 2005;1(2):219-27.
4. Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, 
van den Brand MJ, et al. Cyphering the complexity of coro-
nary artery disease using the Syntax score to predict clinical 
outcome in patients with three-vessel lumen obstruction un-
dergoing percutaneous coronary intervention. Am J Cardiol. 
2007;99(8):1072-81.
5. van Gaal WJ, Ponnuthurai FA, Selvanayagam J, Testa L, Porto I, 
Neubauer S, et al. The Syntax score predicts peri-procedural 
myocardial necrosis during percutaneous coronary interven-
tion. Int J Cardiol. 2009;135(1):60-5.
6. Mattos LA, Lemos PA, Rassi A Jr, Marin-Neto JA, Sousa AGMR, 
Devito FS, et al. Diretrizes da Sociedade Brasileira de Cardio-
logia – intervenção coronária percutânea e métodos adjuntos 
diagnósticos em cardiologia intervencionista (II edição – 2008). 
Arq Bras Cardiol. 2008;91(6 Supl 1):1-58.
7.  Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, 
et al. Clinical end points in coronary stent trials: a case for 
standardized definitions. Circulation. 2007;115(17):2344-51.
8.  Serruys PW, Daemen J, Morice MC, De Bruyne B, Colombo A, 
Macaya C, et al. Three year follow-up of the ARTS-II – sirolimus-
elu ting stents for the treatment of patients with multivessel 
coronary artery diease. EuroIntervention. 2008;3(4):450-9.
9. Windecker S, Serruys PW, Wandel S, Buszman P, Trznadel S, 
Linke A, et al. Biolimus-eluting stent with biodegradable 
polymer versus sirolimus-eluting stent with durable polymer 
for coronary revascularisation (LEADERS): a randomised non-
in feriority trial. Lancet. 2008;372(9644):1163-73.
10. Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel MA, 
van Es GA, et al. Value of the SYNTAX score for risk assessment 
in the all-comers population of the randomized multicenter 
LEADERS (Limus Eluted from A Durable versus ERodable Stent 
coating) trial. J Am Coll Cardiol. 2010;56(4):272-7.
11. Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, Buszman PE, 
et al. Comparison of zotarolimus-eluting and everolimus-elu ting 
coronary stents. N Engl J Med. 2010;363(2):136-46.
12. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’t Veer M, 
et al. Fractional flow reserve versus angiography for guid-
ing percutaneous coronary intervention. N Engl J Med. 
2009;360(3):213-24.
